Indications for use
As part of combined therapy in adults:
- cerebral infarction;
- consequences of cerebrovascular diseases (cerebral infarction, cerebral atherosclerosis);
- toxic and hypoxic encephalopathy in acute and chronic intoxication, endotoxicosis, postanesthetic depression of consciousness, as well as for the prevention and treatment of hypoxic encephalopathy during cardiac surgery using assisted circulation.
As part of combined therapy in children (including preterm newborns with a gestational age of 28–36 weeks) in the neonatal period:
- cerebral ischemia.